← Back
$CLDI All transactions

Calidi Biotherapeutics, Inc.

A

$ Value

Shares

30,000

Price

Filed

Sep 5

Insider

Name

Jackson Andrew C.

Title

Chief Financial Officer

CIK

0001636738

Roles

Officer

Transaction Details

Transaction Date

2025-09-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

30,000

Footnotes

Pursuant to the Issuer's 2023 Equity Incentive Plan (the "2023 Plan"), on September 3, 2025 (the "Grant Date"), the Reporting Person was granted 30,000 incentive stock options (the "Options") at an exercise price of $1.58, which is equal to the closing price of the Issuer's common stock on the Grant Date. 25% of the options will vest upon the one (1) year anniversary of 9/03/2025, and the remaining 75% of the options will vest in 1/36th installments on the last day of each monthly period subject to the Reporting Person's continued service to the Issuer. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person.

Filing Info

Accession No.

0001641172-25-026781

Form Type

4

Issuer CIK

0001855485

Jackson Andrew C.'s History

Date Ticker Type Value
2025-09-03 CLDI A
2025-08-21 CLDI $5K
2025-08-21 CLDI

Other Insiders at CLDI (90d)

No other insider activity at this issuer in the last 90 days.